NYSE:GLOBIT
Assessing Globant (GLOB) Valuation After New AI Deals In Healthcare And Payments
Why Globant Stock Is Back on Investors’ Radar
Globant (GLOB) is drawing fresh attention after two new partnerships: one applying its enterprise AI platform to cancer drug discovery with PharmaMar, and another expanding its role in global payments integration with Adyen.
For you as an investor, these moves sit at the intersection of healthcare AI and financial services technology, two areas where large clients often demand complex, long term solutions rather than one off projects.
See our...